This review evaluates how natural products can enhance therapeutic outcomes in colorectal cancer by targeting the tumor microenvironment.
Colorectal cancer poses a significant clinical challenge, with an alarming annual incidence of nearly 1.88 million new cases and limited therapeutic strategies, especially for advanced stages. The tumor microenvironment represents a complex ecosystem encompassing tumor cells, immune cells, cancer-associated fibroblasts, and extracellular matrix. This ecosystem is pivotal in orchestrating the trajectory of colorectal cancer evolution and can be divided into six microenvironments: acidic, hypoxic, metabolic, immune, microbiota, and stromal. The tumor microenvironment has increasingly garnered attention in oncological research, as modulating these environments presents novel therapeutic avenues for colorectal cancer. This review provides a comprehensive evaluation of the capacity of natural products to modulate the tumor microenvironment and augment colorectal cancer therapeutic outcomes. Additionally, this review underscores seminal clinical and preclinical studies, providing valuable insights to unlock the full potential of natural products in the development of novel drugs to effectively address the challenges posed by colorectal cancer.
No takes yet. Share an insight, caveat, or question.
Tao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: